Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer., PMID:37115489
Potential clinical implications of CD4+CD26high T cells for nivolumab treated melanoma patients., PMID:37170241
The serum concentration and activity of DPP4 is positively related with the severity of hyperthyroidism in patients with Graves' disease., PMID:37350750
Analysis of IL-10 and IL-35 in dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid., PMID:37424368
Discovery of novel thymidylate synthase (TS) inhibitors that influence cancer angiogenesis and metabolic reprogramming in NSCLC cells., PMID:37437348
Comprehensive cell surface protein profiling of human mesenchymal stromal cells from peritoneal dialysis effluent and comparison with those from human bone marrow and adipose tissue., PMID:37603218
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies., PMID:37626869
Dipeptidyl peptidase-4 inhibitor-related pemphigus herpetiformis with antibodies against desmocollin 3., PMID:37680081
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus., PMID:37756379
Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report., PMID:38035149
A self-assembled graphene oxide adjuvant induces both enhanced humoral and cellular immune responses in influenza vaccine., PMID:38036004
In Doxorubicin-Adapted Hodgkin Lymphoma Cells, Acquiring Multidrug Resistance and Improved Immunosuppressive Abilities, Doxorubicin Activity Was Enhanced by Chloroquine and GW4869., PMID:38067159
From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid., PMID:38069109
Novel Pharmacological Treatment Options of Steroid-Refractory Graft-versus-Host Disease., PMID:38094101
A case of anti-laminin γ1 (p200) pemphigoid developed after dipeptidyl peptidase-4 inhibitor administration., PMID:38214494
Association of COVID with Mycosis in General., PMID:38251692
Single-cell atlas of human infrapatellar fat pad and synovium implicates APOE signaling in osteoarthritis pathology., PMID:38266107
HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation., PMID:38284882
ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks., PMID:38371953
DPP Inhibition Enhances the Efficacy of PD-1 Blockade by Remodeling the Tumor Microenvironment in Lewis Lung Carcinoma Model., PMID:38672409
Inactivated Split MERS-CoV Antigen Prevents Lethal Middle East Respiratory Syndrome Coronavirus Infections in Mice., PMID:38675818
A dual-targeting approach using a human bispecific antibody against the receptor-binding domain of the Middle East Respiratory Syndrome Coronavirus., PMID:38697296
Boosting humoral and cellular immunity with enhanced STING activation by hierarchical mesoporous metal-organic framework adjuvants., PMID:38723671
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review., PMID:38753071
A case of immunoglobulin G4-related kidney disease manifesting after dipeptidyl peptidase-4 inhibitor treatment., PMID:38801515
ADA/CD26 axis increases intra-tumor PD-1+CD28+CD8+ T-cell fitness and affects NSCLC prognosis and response to ICB., PMID:38915783
Phenotypic characterisation of bovine alveolar macrophages reveals two major subsets with differential expression of CD163., PMID:38951667
Soluble CD26: From Suggested Biomarker for Cancer Diagnosis to Plausible Marker for Dynamic Monitoring of Immunotherapy., PMID:39001488
CD38/NAD+ glycohydrolase and associated antigens in chronic lymphocytic leukaemia: From interconnected signalling pathways to therapeutic strategies., PMID:39009062
Peptide array screening with anti-GLP-1 monoclonal antibody: Discovery of cysteine-containing DPP-IV inhibitory peptides., PMID:39085020
Association between glucose-lowering drugs and circulating insulin antibodies induced by insulin therapy in patients with type 2 diabetes., PMID:39099829
A Retrospective Comparison of Diagnostic Tools of Bullous Pemphigoid for Elderly Patients., PMID:39108027
Pan-beta-coronavirus subunit vaccine prevents SARS-CoV-2 Omicron, SARS-CoV, and MERS-CoV challenge., PMID:39189731
Cold-adapted live attenuated MERS-CoV vaccine strain remains attenuated in mice after multiple passages in Vero cells at 37 °C., PMID:39240318
Serum interleukin-10 level is increased and correlated positively with disease severity in patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid., PMID:39428667
Clinical characteristics and outcomes of dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid patients: A retrospective study., PMID:39442884
Effect of switching from dulaglutide to tirzepatide on blood glucose and renal function., PMID:39462543
Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes., PMID:39582250
Design of a Magnetic Nanoplatform Based on CD26 Targeting and HSP90 Inhibition for Apoptosis and Ferroptosis-Mediated Elimination of Senescent Cells., PMID:39631769
Detection and Evaluation of Procalcitonin Variants As Diagnostic Tools in Systemic Inflammation., PMID:39636188
Vitamin D Supplementation as a Therapeutic Strategy in Autoimmune Diabetes: Insights and Implications for LADA Management., PMID:39683465
Dipeptidyl peptidase 4 is a cofactor for porcine epidemic diarrhea virus infection., PMID:39765007
Bullous pemphigoid: A practical approach to diagnosis and management in the modern era., PMID:39914667
Molecular basis of convergent evolution of ACE2 receptor utilization among HKU5 coronaviruses., PMID:39922192
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution., PMID:40027745
Gastroprotective Effect of Linagliptin on Indomethacin-Induced Gastric Ulceration in Mice: Crosstalk Between Oxidative Stress and Inflammasome Pathways., PMID:40109745
ACE2 utilization of HKU25 clade MERS-related coronaviruses with broad geographic distribution., PMID:40162213
Anti-S2 antibodies responsible for the SARS-CoV-2 infection-induced serological cross-reactivity against MERS-CoV and MERS-related coronaviruses., PMID:40226608
Development of DPP-4-resistant CXCL9-Fc and CXCL10-Fc chemokines for effective cancer immunotherapy., PMID:40238455
Targeting the senescent surfaceome through DPP4 antibody-functionalized nanoparticles. An application to cancer therapy., PMID:40494025
For research use only. Not for human or drug use.
